{"id":"tp-51134","type":"article-newspaper","title":"iRhythm Raises 2026 Revenue Outlook and Expects 2027 Zio MCT FDA Filing","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/51134","datePublished":"2026-11-07T22:10:53.000Z","dateModified":"2026-11-07T22:10:53.000Z","language":"en","abstract":"Third-quarter revenue was $221.6 million, up nearly 15% from a year earlier. iRhythm expects Zio AT revenue to decline about 10% in the fourth quarter.","section":"Business","references":[]}